HLVX - HilleVax - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-131.7M

Cash

272.7M

Avg Qtr Burn

-25.96M

Short % of Float

7.45%

Insider Ownership

17.14%

Institutional Own.

90.85%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HIL-216 Details Norovirus	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
HIL-214 Details Norovirus	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.